vs
Proto Labs Inc（PRLB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Proto Labs Inc的季度营收约是RIGEL PHARMACEUTICALS INC的2.0倍（$139.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.8%，领先378.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 10.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.3%）
Proto Labs是一家提供快速制造服务的企业，可通过3D打印、CNC加工、钣金加工以及注塑成型工艺，为客户生产用于原型制作和量产的定制零部件，产品广泛应用于医疗设备、航空航天、电子、家电、汽车、消费品等多个领域，公司总部位于美国明尼苏达州，在美国多地设有生产基地。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PRLB vs RIGL — 直观对比
营收规模更大
PRLB
是对方的2.0倍
$69.8M
营收增速更快
RIGL
高出10.8%
10.4%
净利率更高
RIGL
高出378.2%
5.8%
两年增速更快
RIGL
近两年复合增速
5.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.3M | $69.8M |
| 净利润 | $8.1M | $268.1M |
| 毛利率 | 45.6% | 91.5% |
| 营业利润率 | 7.1% | 33.2% |
| 净利率 | 5.8% | 384.0% |
| 营收同比 | 10.4% | 21.2% |
| 净利润同比 | 125.4% | 1769.2% |
| 每股收益（稀释后） | $0.29 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRLBRIGL
| Q1 26 | $139.3M | — | ||
| Q4 25 | $136.5M | $69.8M | ||
| Q3 25 | $135.4M | $69.5M | ||
| Q2 25 | $135.1M | $101.7M | ||
| Q1 25 | $126.2M | $53.3M | ||
| Q4 24 | $121.8M | $57.6M | ||
| Q3 24 | $125.6M | $55.3M | ||
| Q2 24 | $125.6M | $36.8M |
净利润PRLBRIGL
| Q1 26 | $8.1M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $7.2M | $27.9M | ||
| Q2 25 | $4.4M | $59.6M | ||
| Q1 25 | $3.6M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $7.2M | $12.4M | ||
| Q2 24 | $4.5M | $-1.0M |
毛利率PRLBRIGL
| Q1 26 | 45.6% | — | ||
| Q4 25 | 44.2% | 91.5% | ||
| Q3 25 | 45.3% | 93.2% | ||
| Q2 25 | 44.3% | 95.6% | ||
| Q1 25 | 44.1% | 91.7% | ||
| Q4 24 | 42.7% | 89.9% | ||
| Q3 24 | 45.6% | 85.5% | ||
| Q2 24 | 45.0% | 92.4% |
营业利润率PRLBRIGL
| Q1 26 | 7.1% | — | ||
| Q4 25 | 5.0% | 33.2% | ||
| Q3 25 | 6.5% | 40.9% | ||
| Q2 25 | 3.7% | 60.1% | ||
| Q1 25 | 3.6% | 23.9% | ||
| Q4 24 | -1.2% | 28.9% | ||
| Q3 24 | 6.8% | 25.4% | ||
| Q2 24 | 4.8% | 1.2% |
净利率PRLBRIGL
| Q1 26 | 5.8% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 5.3% | 40.2% | ||
| Q2 25 | 3.3% | 58.6% | ||
| Q1 25 | 2.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 5.7% | 22.5% | ||
| Q2 24 | 3.6% | -2.8% |
每股收益（稀释后）PRLBRIGL
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.25 | $14.11 | ||
| Q3 25 | $0.30 | $1.46 | ||
| Q2 25 | $0.18 | $3.28 | ||
| Q1 25 | $0.15 | $0.63 | ||
| Q4 24 | $-0.01 | $0.82 | ||
| Q3 24 | $0.29 | $0.70 | ||
| Q2 24 | $0.18 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $683.1M | $391.5M |
| 总资产 | $778.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PRLBRIGL
| Q1 26 | $124.0M | — | ||
| Q4 25 | $128.1M | $155.0M | ||
| Q3 25 | $119.2M | $137.1M | ||
| Q2 25 | $103.2M | $108.4M | ||
| Q1 25 | $96.8M | $77.1M | ||
| Q4 24 | $103.1M | $77.3M | ||
| Q3 24 | $100.5M | $61.1M | ||
| Q2 24 | $112.9M | $49.1M |
总债务PRLBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益PRLBRIGL
| Q1 26 | $683.1M | — | ||
| Q4 25 | $673.9M | $391.5M | ||
| Q3 25 | $664.7M | $117.6M | ||
| Q2 25 | $664.7M | $81.9M | ||
| Q1 25 | $656.8M | $18.6M | ||
| Q4 24 | $670.2M | $3.3M | ||
| Q3 24 | $680.0M | $-14.6M | ||
| Q2 24 | $685.2M | $-29.9M |
总资产PRLBRIGL
| Q1 26 | $778.6M | — | ||
| Q4 25 | $763.4M | $513.6M | ||
| Q3 25 | $756.9M | $242.5M | ||
| Q2 25 | $743.3M | $206.7M | ||
| Q1 25 | $737.5M | $176.0M | ||
| Q4 24 | $743.5M | $164.0M | ||
| Q3 24 | $753.8M | $139.4M | ||
| Q2 24 | $758.2M | $128.4M |
负债/权益比PRLBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.16× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRLBRIGL
| Q1 26 | $17.5M | — | ||
| Q4 25 | $16.5M | $22.0M | ||
| Q3 25 | $29.1M | $24.0M | ||
| Q2 25 | $10.6M | $30.5M | ||
| Q1 25 | $18.4M | $-893.0K | ||
| Q4 24 | $17.3M | $14.5M | ||
| Q3 24 | $24.8M | $21.7M | ||
| Q2 24 | $14.4M | $302.0K |
自由现金流PRLBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $8.4M | — | ||
| Q3 25 | $25.0M | — | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $17.1M | — | ||
| Q4 24 | $16.5M | — | ||
| Q3 24 | $23.2M | — | ||
| Q2 24 | $10.2M | — |
自由现金流率PRLBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | — | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 13.6% | — | ||
| Q4 24 | 13.5% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | 8.2% | — |
资本支出强度PRLBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 3.3% | — |
现金转化率PRLBRIGL
| Q1 26 | 2.16× | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.03× | 0.86× | ||
| Q2 25 | 2.39× | 0.51× | ||
| Q1 25 | 5.11× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.44× | 1.75× | ||
| Q2 24 | 3.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRLB
| CNC Machining | $63.2M | 45% |
| Injection Molding | $51.1M | 37% |
| 3D Printing | $20.5M | 15% |
| Sheet Metal | $4.4M | 3% |
| Other Revenue | $207.0K | 0% |
RIGL
暂无分部数据
